Abstract
Coronary artery disease (CAD) continues to be a leading cause of death in the USA and throughout the world. Allina Health System, with the Minneapolis Heart Institute at Abbott Northwestern, recently announced a long-term study in the city of New Ulm, MN, to reduce risk factors for myocardial infarction and, ultimately, reduce myocardial infarction incidence. To achieve this goal, the focus will be on health promotion interventions and primary and secondary prevention strategies for CAD that are innovative, community-wide, and able to impact individuals at home, at work, in their community, and in their health care settings. Factors considered in selecting this city included the identification of health as a priority by the community, readiness and willingness of the community to change, the ability to provide and deliver systematic care, and partnerships established across multiple disciplines and sectors centered on improved health. The following stakeholders will be engaged: the community, employers, public health, health care, and health plans. Unique aspects of the intervention include centralized healthcare, including an automated medical record; genetic testing; integrated behavioral interventions; social environmental change and social circumstances; health promotion, primary prevention and secondary prevention interventions; advanced diagnostics and imaging; and state-of-the-art therapy.
Similar content being viewed by others
References
Lopez, A. D., Mathers, C. D., Jamison, D. T., & Murray, C. J. L. (2006). Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet, 367, 1747–1757.
Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, S., et al. (2008). Heart disease and stroke statistics—2008 update: A report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation, 117, e25–e146.
Wald, N. J., Law, M. R., Morris, J. K., & Jordan, R. (2003). Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. British Medical Journal, 326, 1427–1431.
Blood Pressure Lowering Treatment Trialist’s Collaboration (2003). Effect of different blood pressure lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet, 362, 1527–1535.
Law, M. R., Wald, N. J., & Rudnicka, A. (2003). Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease and stroke: systematic review and meta-analysis. British Medical Journal, 2003, 1423–1427.
Antithrombotic Trialists’ Collaboration (2002). Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. British Medical Journal, 324, 71–86.
Jones, D. W., Peterson, E. D., Bonow, R. O., Masoudi, F. A., Fonarow, G. C., Smith Jr., S. C., et al. (2008). Translating research into practice for healthcare providers. The American Heart Association's Strategy for Building Healthier Lives, Free of Cardiovascular Diseases and Stroke. Circulation, 118, 000–000.
Henry, T. D., Sharkey, S. W., Burke, M. N., Chavez, I. J., Graham, K. J., Henry, C. R., et al. (2007). A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction. Circulation, 116(7), 721–728.
Lim, S. S., Gaziano, T. A., Gakidou, E., Reddy, K. S., Farzadfar, F., Lozano, R., et al. (2007). Prevention of cardiovascular disease in high-risk individuals in low-income and middle-income countries: health effects and costs. Lancet, 370, 2054–2062.
Mokdad, A. H., Marks, J. S., Stroup, J. S., & Gerberding, J. L. (2004). Actual causes of death in the United States, 2000. Journal of the American Medical Association, 291, 1238–1245 (Errata, JAMA 2005; 293–294, 298).
Luepker, R. V., Murray, D. M., Jacobs, D. R., Mittelmark, M. B., Bracht, N., Carlaw, R., et al. (1994). Community education for cardiovascular disease prevention: risk factor changes in the Minnesota Heart Health Program. American Journal of Public Health, 84, 1383–1393.
Brownson, R. C., Smith, C. A., Pratt, M., Mack, N. E., Jackson-Thompson, J., Dean, C. G., et al. (1996). Preventing cardiovascular disease through community-based risk reduction: the Bootheel Heart Health Project. American Journal of Public Health, 86, 206–213.
Carleton, R. A., Lasater, T. M., Assaf, A. R., Feldman, H. A., McKinlay, S., & the Pawtucket Heart Health Program Writing Group (1995). The Pawtucket Heart Health Program: community changes in cardiovascular risk factors and projected disease risk. Journal of Public Health, 85, 777–785.
Eaton, C. B., Lapane, K. L., Garber, C. E., Gans, K. M., Lasater, T. M., & Carleton, R. A. (1999). Effects of a community-based intervention on physical activity: The Pawtucket Heart Health Program. American Journal of Public Health, 89, 1741–1744.
Barnett, E., Anderson, T., Blosnich, J., Halverson, J., & Novak, J. (2005). Promoting cardiovascular health: From individual goals to social environmental change. American Journal of Preventive Medicine, 29(5S1), 107–112.
Puska, P., Salonen, J. T., Nissinen, A., Tuomilehto, J., Vartiainen, E., Korhonen, H., et al. (1983). Change in risk factors for coronary heart disease during 10 years of a community intervention programme (North Karelia project). British Medical Journal, 287, 1840–1844.
Puska, P., Pietnen, P., & Uusitalow, U. (2002). Influencing public nutrition for non-communicable disease prevention: from community intervention to national programme—experiences from Finland. Public Health Nutrition, 5, 245–251.
Mensah, G. A., Dietz, W. H., Harris, V. B., Henson, R., Labarthe, D. R., Vinicor, F., et al. (2005). Prevention and control of coronary heart disease and stroke—nomenclature for prevention approaches in public health. A statement for public health practice from the Centers for Disease Control and Prevention. American Journal of Preventive Medicine, 29(5S1), 152–157.
Schroeder, S. A. (2007). We can do better—improving the health of American people. New England Journal of Medicine, 357, 1221–1228.
McGinnis, J. M., & Goege, W. H. (1993). Actual causes of death in the United States. Journal of the American Medical Association, 270, 2207–2212.
McGinnis, J. M., Williams-Russo, P., & Knickman, J. R. (2002). The case for active policy attention to health promotion. Health Affairs, 21(2), 28–93.
Minnesota Department of Health (2008) Facts about heart disease and stroke in Minnesota. http://health.state.mn.us/divs/hpcd/chp/cvh/. Accessed 29 July 2008.
Pronk, N. P., & Boucher, J. (1999). Systems approach to childhood and adolescent obesity prevention and treatment in a managed care organization. International Journal of Obesity, 23, S38–S42.
Trujillo, E., Davis, C., & Milner, J. (2006). Nutrigenomics, proteomics, metabolomics, and the practice of dietetics. Journal of the American Dietetic Association, 106, 403–413.
DeBusk, R. M., Fogarty, C. P., Ordovas, J. M., & Kornman, K. D. (2005). Nutritional genomics in practice: where do we begin? Journal of the American Dietetic Association, 105, 589–598.
Matson-Koffman, D. M., Goetzel, R. Z., Anwuri, V. V., Shore, K. K., Orenstein, D., & LaPier, T. (2005). Heart healthy and stroke free: successful business strategies to prevent cardiovascular disease. American Journal of Preventive Medicine, 29(5S1), 113–121.
Centers for Disease Control and Prevention (2004). Heart-healthy and smoke-free states: a communication plan for policy and environmental change. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention.
Eyre, H., Kahn, R., Robertson, R. M., & with the ACS/ADA/AHA Collaborative Writing Committee (2004). Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation, 109, 3244–3255.
Smith, S. C., Allen, J., Blair, S. N., Bonow, R. O., Brass, L. M., Fonarow, G. C., et al. (2006). AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 Update: Endorsed by the National Heart, Lung, and Blood Institute. Circulation, 113, 2363–2372.
Detrano, R., Guerci, A. D., Carr, J. J., Bild, D. E., Burke, G., Folsom, A. R., et al. (2008). Coronary calcium as a predictor of coronary events in four racial or ethnic groups. New England Journal of Medicine, 358, 1336–1345.
Pelzel, J. M., Lesser, J. F., Knickelbine, T., Flygenring, B., Tadros, G., & Schwartz, R. S. (2007). Multidetector CT coronary angiography: where we are and where we are going. Catheterization and Cariovascular Interventions, 69, 159–171.
Hunt, A., Jacobs, A. K., Gibbons, R. J., Gregoratos, G., Halperin, J. L., Hiratzka, L. F., et al. (2004). ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. Circulation, 110, e82–e293.
Acknowledgement
The authors would like to acknowledge Allina Health System, the New Ulm Medical Center, the Abbott Northwestern Foundation, and the Minneapolis Heart Institute Foundation for their support of this project. The Allina Center for Healthcare Innovation has committed to providing funding for this project over the next 10 years. The Abbott Northwestern Foundation and the Minneapolis Heart Institute Foundation will seek matching funding to support this project. We applaud these organizations for their ongoing commitment to improved health and health care practices.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boucher, J.L., Pereira, R.F., Graham, K.J. et al. The Heart of New Ulm: A Vision for the Future. J. of Cardiovasc. Trans. Res. 1, 310–316 (2008). https://doi.org/10.1007/s12265-008-9077-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-008-9077-2